Development, Partnership, Innovation.
Neos Therapeutics® is a privately owned drug delivery and full service contract manufacturing company serving prescription pharmaceutical and consumer healthcare markets.
Neos’ proprietary drug delivery technology platform is clinically proven. Our operating model is to develop prescription and OTC products working in partnership with healthcare companies. The Neos technology enables creation of innovative dosage forms, notably controlled release (CR) liquids and CR orally disintegrating tablets (ODTs).
Our expertise, technology and full service contract manufacturing spans the range of oral drug dosage forms from conventional tablets and capsules to the truly unique CR liquids and CR ODTs. Neos’ proprietary formulation technology, Dynamic Time Release Suspension® (DTRS®), has been used to develop a newly approved Generic Tussionex® extended release suspension product. The product was developed through collaboration with Cornerstone Therapeutics Inc. and Coating Place, Inc., and will be exclusively manufactured by Neos Therapeutics.
A dedicated R&D team working in our state-of-the-art, FDA-approved facility enables Neos to collaborate effectively from the initial stage of drug development through finished packaging for commercial sale. Throughout the entire process we strive to meet our partner’s needs and provide unique product offerings.
- Liquid Technology: Dynamic Time Release Suspension® (DTRS®)
- ODT Technology: Rapidly Disintegrating Ionic Masking (RDIM)
>> Read More
- Controlled Substances
- Liquids & Suspension
- Tablets & Capsules
- Unique Dosage Forms ODTs